Top Machine Learning Companies in Dallas, TX (38)

Strong Revenue Growth: ARR is reported as more than tripled in 2025, with annual recurring subscription and service revenue increasing by over 220%. Growth is attributed to new and expanding relationships with private equity sponsors and their portfolio companies.

Market Expansion: Office openings and relocations across Chicago, Dallas, New York, and Toronto, plus expanded sponsor footprint and portfolio reach, indicate widening geographic and commercial coverage. The company cites doubling sponsor partnerships and reach into a network representing about $400B AUM.

Strong Hiring & Retention: Headcount is estimated to have risen sharply over 2023–2026, and multiple executive appointments (e.g., EVPs for Finance & Corporate Development and for Technology & Operations) were made to support scaling. Added locations and planned team growth in hubs like Chicago and New York further signal ongoing talent expansion.

Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.

Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.

Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.

Strong Revenue Growth: Revenue increased year over year in the latest quarters, with momentum accelerating into Q2 2026. Monetization per user improved, helping top-line growth outpace audience expansion.

Healthy Cash Flow: Adjusted EBITDA and free cash flow rose sharply, and the company generated positive free cash flow in the latest quarter. These gains indicate stronger operating leverage versus a year earlier.

Diversified Revenue Streams: Subscription and other direct-revenue products such as Snapchat+ expanded rapidly alongside core advertising. “Other revenue” grew significantly and the direct-revenue run rate scaled materially.

Investor Backing & Capital Strength: New Mountain Capital’s acquisition and combination of Machinify with Rawlings, Apixio’s Payment Integrity business, and VARIS—followed by the take‑private of Performant—signal strong sponsor support and access to capital. Feedback suggests this backing has enabled rapid scale-up and broadened capabilities across the payment continuum.

Market Expansion: The combined entity reports service to 60+ (and in some materials 75–85+) health plans, including many of the top 20, and expansion into government programs—evidence of widening market reach. Company communications and industry coverage indicate increased client footprint and data assets after 2025’s roll‑ups.

Future-Ready Strategy: An AI‑first platform focused on pre‑pay and concurrent review, along with a unified brand around end‑to‑end “healthcare intelligence,” aligns with payer shifts toward earlier interventions in the payment lifecycle. Product launches (e.g., AI-driven claim editing) and repositioning suggest a strategy oriented to next‑generation payment accuracy.

Future-Ready Strategy: Public initiatives around generative AI, agentic systems, and a build-once, scale-globally platform approach indicate a deliberate pivot toward AI-era capabilities. Consolidating technology, AI, product and design is framed as simplifying org design and aligning skills to current needs.

Innovation-Driven Growth: Walmart Global Tech is repeatedly characterized as operating at the forefront of AI, automation, cloud, and omnichannel tech, shipping production systems like a GenAI shopping assistant and scaled supply-chain automation. Investments in ML/data platforms, developer productivity tooling, and retail media technology point to capability-led expansion.

Strategic Partnerships: Deep collaborations with Microsoft/Azure OpenAI and Google for conversational commerce, plus robotics and advertising moves such as the Vibe.co acquisition, strengthen the roadmap and speed of deployment. These alliances are presented as accelerating AI-first shopping experiences and retail media growth.

Strong Revenue Growth: External accolades indicate outsized multi‑year revenue expansion, including being named Adweek’s 2023 #1 Fastest Growing Agency and ranking No. 58 on the 2024 Inc. 5000. Leadership communications reference continued momentum into 2026, reinforcing a trajectory of ongoing top‑line gains.

Innovation-Driven Growth: Capability buildouts in AI and automation—such as launching Catapult and acquiring BotsCrew—align offerings to rising client demand for AI agents and automation. These investments broaden the firm’s digital transformation remit and strengthen its growth platform.

Market Expansion: Enterprise‑level remits and federal wins, including a direct AOR role with the U.S. Air Force Rapid Sustainment Office, show reach beyond project work. Multiple U.S. offices, a rising LinkedIn headcount band, and a larger Cincinnati footprint point to a widening geographic presence.

Strong Market Position & Advantage: Longevity, multi-country operations, and inclusion in independent analyst coverage point to a credible standing in outsourced industrial maintenance. Repeat recognition in reputable programs and safety/innovation honors further reinforce mainstream competitiveness in its niche.

Innovation-Driven Growth: Enhancements to the Reliability 360 machine-health platform, remote diagnostics, and API-based CMMS integration illustrate ongoing technology-led expansion of offerings. A focus on predictive analytics and outcomes-based maintenance signals continued investment in differentiated capabilities.

Customer Loyalty & Retention: High contract retention and multi-plant scale-outs from pilots indicate durable relationships and expanding scope within existing accounts. Broad multi-site support across the U.S., U.K., and Mexico suggests embedded, recurring engagement models.

Strong Revenue Growth: Revenue is described as rising from about $78 million in 2024 to $110 million in 2025, indicating a clear acceleration in topline momentum. Additional signals like increased payment volume and deposits are cited alongside this step-up.

Investor Backing & Capital Strength: Funding capacity is reinforced by renewed and expanded credit facilities and new lender participation (e.g., adding Blue Owl), which is presented as lender confidence and added lending headroom. Forward-flow and warehouse structures are repeatedly referenced as enabling increased origination capacity.

Strategic Partnerships: Embedded-capital partnerships with SMB software and platform providers (e.g., Wave, Cantaloupe, EverCommerce/Joist/Invoice Simple, Autobooks) are highlighted as a core distribution engine. This partner-first approach is framed as a durable go-to-market advantage for scaling embedded working-capital offers.

Strong Revenue Growth: Feedback suggests revenue expanded rapidly, including a reported 46% growth in the year before March 2024 and earlier growth from $1.9M in 2017 to over $10M by 2020. Signals like increased headcount and expanded geographic footprint further align with ongoing top-line momentum.

Market Expansion: Feedback suggests the company expanded across the U.S. and Latin America, opening offices in Bogotá, Medellín, Chicago, and operating in multiple countries and continents. Joining major AI partner networks indicates continued penetration into broader markets and ecosystems.

Strategic Partnerships: Feedback suggests entry into the OpenAI and Claude Partner Networks, alongside Google Cloud and Databricks relationships, strengthening ecosystem reach. These alliances appear to support enterprise delivery and go-to-market scalability.

Strong Revenue Growth: Broad-based top-line gains are evident with net interest income and fee income both increasing year over year, supported by net interest margin expansion. Management materials also point to peer-leading revenue momentum in 2026 alongside positive operating leverage.

Profitability: Earnings power is expanding as EPS and pre-provision net revenue rise alongside margin improvement. Loan and deposit growth further reinforce the trajectory of rising earnings.

Diversified Revenue Streams: The Private Bank and Wealth businesses, together with Capital Markets, are contributing more meaningfully to earnings, including a specific EPS lift from the Private Bank. Record or near-record fees in Wealth and Capital Markets indicate a healthier mix beyond spread income.

Strong Market Position & Advantage: The company is positioned as a front-runner within a specific U.S. niche—fully autonomous, commercial-grade, electric mowers sold to landscape contractors—supported by product differentiation and a contractor-focused go-to-market approach.

Investor Backing & Capital Strength: Recent and repeated funding rounds alongside a physical manufacturing/HQ expansion indicate continued access to capital to support commercialization and scaling efforts.

Cost & Operational Efficiency: Signals of an operational ramp—planning to build 100+ units for a season, ramping weekly production, and expanding service coverage—suggest movement toward more repeatable production and field operations.

Innovation-Driven Growth: Iterative Health is positioned as an emerging leader in AI-assisted gastroenterology with FDA-cleared, real-time polyp detection and ongoing 510(k) iteration activity through late 2025. Peer-reviewed U.S. clinical evidence and continued conference data releases reinforce credibility and support continued adoption momentum.

Strategic Partnerships: Commercialization and access are reinforced by partnerships such as Provation for U.S. commercialization and provider-network collaborations including GI Alliance and One GI to expand clinical research capacity. These relationships indicate a scale-up model that combines technology deployment with embedded clinical operations across multiple sites.

Strong Hiring & Retention: Active hiring across a wide range of functions with dozens of open roles signals investment in operational capacity and near-term expansion. Recent executive additions (e.g., President/CFO and a CMO focused on hepatology and obesity) further support an organizational build-out aligned to growth.